business

Zealand Pharma shares crash 24% as obesity drug side effects overshadow trial data

Investing.com · Jun 8, 2026, 11:42 AM · Also reported by 2 other sources

Read full story on Investing.com → More top stories

Also covered by

MarketWatch Zealand Pharma loses a fifth of its value as many users gave up taking weight-loss drug during trial STAT News STAT+: Pharmalittle: We’re reading about Lilly and Pfizer obesity drug data, Roche and J&J deals, and more

Aggregated and edited by the Scoop newsroom. We surface news from Investing.com alongside other reporting so you can compare coverage in one place. Editorial policy · Corrections · About Scoop

Zealand Pharma shares crash 24% as obesity drug side effects overshadow trial data

Also covered by

More in business